Bold Voices - December 2011 - (Page 12)

AT THE BEDSIDE FDA’s Treatment Recommendations for Simvastatin 80 The U.S. Food and Drug Administration (FDA) recommends strong limitations on simvastatin 80 mg, a common cholesterol-lowering fda.gov podcast drug sold by Merck as helps you prepare Zocor, to reduce risk of muscle damage. to answer patients’ In a safety announcement, FDA says to keep questions. patients on simvastatin 80 mg “only if they have been taking this dose for 12 or more months without evidence of muscle toxicity.” It says to not start simvastatin 80 mg in new patients, including patients on lower doses of the drug. For health professionals, FDA further recommends: • Place patients who do not meet their LDL cholesterol (LDL-C) goal while taking simvastatin 40 mg on alternative LDL-C lowering treatments that provide greater LDL-C lowering. • Follow the recommendations in the simvastatin-containing medicine labels regarding drugs that may increase the risk of muscle injury when used with simvastatin. • For patients who need to start on a drug that interacts with simvastatin, switch them to an alternative statin with less potential for drug-drug interaction. • Report adverse events involving simvastatin-containing medicines to the FDA MedWatch program. • Be prepared to answer your patients’ questions. Start with this podcast at fda.gov, “FDA Drug Safety Podcast for Healthcare Professionals: New Restrictions, Contraindications, and Dose Limitations for Zocor (Simvastatin) to Reduce the Risk of Muscle Injury,” or click on the link in the December 2011 AACN Bold Voices digital edition available at www.aacn.org /aacnboldvoices. Webcasts Available for 24/7 Viewing Did you know www.aacn.org/ntiwebcasts links you to more than two dozen webcasts from sessions at the National Teaching Institute & Critical Care Exposition? For example, learn about the physiological effects and symptoms associated with major toxidromes and their treatment therapies, when you tune into Ann Lystrup’s informative presentation, “Oh, Grandma, What a Very Big Medication List You Have: Toxidromes Every Critical Care Nurse Should Know.” Sponsored by GE Healthcare, AACN members and nonmembers receive complimentary CE credit. 12 www.aacnboldvoicesonline.org DECEMBER 2011 http://www.fda.gov http://www.fda.gov/Drugs/DrugSafety/ucm256581.htm http://www.fda.gov/Drugs/DrugSafety/ucm256581.htm http://www.fda.gov http://www.aacn.org/aacnboldvoices http://www.aacn.org/aacnboldvoices http://www.aacn.org/ntiwebcasts http://www.themedicalcenterofplano.com http://www.themedicalcenterofplano.com http://www.aacnboldvoicesonline.org

Table of Contents for the Digital Edition of Bold Voices - December 2011

Front/Digital Edition Viewing Guide
Another Angle
AACN Boards and Contact Information
Dec. 19 Deadline: National Awards Recognize Excellence, Leadership in HAI Prevention
Box Office Hit 'Contagion' Raises Questions About Virus
New Privacy Recommendations for Storing Newborn Screening Specimens
Motor Training Can Advance Social Development in Infants With Autism
In-Hospital Mobility Benefits Older Patients
NSAIDs May Harm Patients with Heart Disease, Hypertension
Pain Code' Encourages Use of Maximum Dosage
FDA's Treatment Recommendations for Simvastatin 80
Study Identifies Predictors of Sudden Cardiac Death Versus Surviving Heart Attack
Study Seeks Initiator of Post-Trauma Intestinal Cell Damage
Australian Study: 'How Dangerous is a Day in Hospital'
In Our Journals
ICU Staff Composition May Decrease Burnout
Use of Manikins May Improve Emergency Care
Celebrate Certification
AACN Financials
Letters
From the President
Back

Bold Voices - December 2011

http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201911
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201910
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201909
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201908
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201907
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201906
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201905
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201904
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201903
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201902
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201901
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201812
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201811
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201810
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201809
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201808
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201807
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201806
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201805
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201804
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201803
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201802
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201801
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201712
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201711
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201710
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201709
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201708
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201707
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201706
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201705
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201704
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201703
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201702
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201701
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201612
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201611
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201610
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201609
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201608
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201607
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201606
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201605
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201604
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201603
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201602
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201601
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201512
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201511
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201510
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201509
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201508
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201507
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201506
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201505
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201504
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201503
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201502
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201501
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201412
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201411
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201410
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201409
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201408
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201407
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201406
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201405
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201404
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201403
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201402
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201401
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201312
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201311
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201310
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201309
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201308
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201307
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201306
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201305
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201304
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201303
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201302
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201301
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201212
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201211
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201210
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201209
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201208
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201207
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201206
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201205
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201204
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201203
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201202
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201201
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201112
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201111
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201110
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201109
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201108
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201107
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201106
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201105
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201104
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201103
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201102
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201101
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201012
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201011
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201010
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201009
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201008
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201007
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201006
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201005
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201004
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201003
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201002
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_201001
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_200912
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_200911
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_200910
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_200909
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_200908
http://www.nxtbook.com/nxtbooks/aacn/boldvoices_200907
http://www.nxtbookMEDIA.com